CEO to review dronabinol, a Phase 3-ready medicine for the treatment of obstructive sleep apnea, and…
Continue ReadingTag: rspi
RespireRx Pharmaceuticals Inc. Announces Positive Results from Phase 2B PACE Study Conducted by the University of Illinois Dronabinol Reduces Symptoms of Obstructive Sleep Apnea
GLEN ROCK, NJ -- (Marketwired) -- 12/23/16 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the…
Continue ReadingRespireRx Pharmaceuticals Inc. Announces Data for CX1739 Clinical Study in Opioid Induced Respiratory Depression
GLEN ROCK, NJ — (Marketwired) — 12/15/16 — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the…
Continue Reading